Showing results (91-100 of 174) with videos related to

Sort By:
Pageof 18
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|October 23, 2008
Red blood cell transfusion dependence and outcome after allogeneic peripheral blood stem cell transplantation in patients with de novo myelodysplastic syndrome (MDS)Uwe Platzbecker, Martin Bornhäuser, Ulrich Germing, et al.
Haematologica|February 13, 2008
Pegylated granulocyte colony-stimulating factor mobilizes CD34+ cells with different stem and progenitor subsets and distinct functional properties in comparison with unconjugated granulocyte colony-stimulating factorIngmar Bruns, Ulrich Steidl, Johannes C Fischer, et al.
Cancers|February 10, 2024
Smart Conditioning with Venetoclax-Enhanced Sequential FLAMSA + RIC in Patients with High-Risk Myeloid MalignanciesFelicitas Schulz, Paul Jäger, Johanna Tischer, et al.
Experimental Hematology|November 9, 2002
Reliable engraftment, low toxicity, and durable remissions following allogeneic blood stem cell transplantation with minimal conditioningGuido Kobbe, Peter Schneider, Manuel Aivado, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|May 15, 2012
Allogeneic hematopoietic cell transplantation in patients age 60-70 years with de novo high-risk myelodysplastic syndrome or secondary acute myelogenous leukemia: comparison with patients lacking donors who received azacitidineUwe Platzbecker, Johannes Schetelig, Jürgen Finke, et al.
Ejhaem|March 5, 2025
Haploidentical Allogeneic Stem Cell Transplantation as a Superior Alternative for Patients With Mismatch Donors-A Single Center Experience in 152 PatientsPaul Jäger, Benno Biermann, Nora Liebers, et al.
Leukemia & Lymphoma|February 8, 2025
Final analysis of the GMALL-PH-01 trial: phase II study of standard chemotherapy in combination with dasatinib in first line treatment of Philadelphia chromosome positive acute lymphoblastic leukemiaFabian Lang, Andreas Voss, Guido Kobbe, et al.
Blood Advances|June 12, 2026
High-risk single-refractory and double-refractory chronic lymphocytic leukemia: feasibility and impact of alloHCTJoseph Kauer, Isabelle Krämer, Patrick Derigs, et al.
American Journal of Hematology|September 8, 2011
Cancer-testis antigen expression and its epigenetic modulation in acute myeloid leukemiaDjordje Atanackovic, Tim Luetkens, Benjamin Kloth, et al.
Haematologica|October 26, 2010
Allogeneic stem cell transplantation for myelodysplastic syndromes with bone marrow fibrosisNicolaus Kröger, Tatjana Zabelina, Anja van Biezen, et al.
Pageof 18